No such message found

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: SGE1 / Re: Two Considerations - 80% of Revenue going to TPL - badger - LL
24
Mar 24, 2010 11:58AM
8
Mar 24, 2010 12:50PM
1
Mar 24, 2010 01:05PM
3
Mar 24, 2010 01:43PM
2
Mar 24, 2010 01:56PM
4
Mar 24, 2010 04:10PM
1
Mar 24, 2010 04:36PM

What don't you understand about the word "currently"?

I heard the 80/20 thing directly or indirectly from 3 AMS attendees. So either they conspired to lie to me, or it is correct.

And your 84% number, obviously a cum to date basis for that number - meaningless in the context of "currently". Look at 2010 to date (end of last reported Q) - drops to 62%.

Have we had a lot of licensing recently?

Is the need to really push Alliacense activity ASAP important? tik-tok

Will they need more resources to secure licenses (hopefully in masse) once we get a result from the PTO?

Haven't we heard that the company, and apparently TPL, want to better support Alliacense activities?

FWIW.

SGE

5
Mar 24, 2010 05:52PM
2
Mar 24, 2010 06:21PM
6
Mar 24, 2010 07:02PM
1
Mar 24, 2010 08:21PM
Share
New Message
Please login to post a reply